Photronics Reports Fourth Quarter and Fiscal Year 2012 Results
-
Quarterly sales of
$104.2 million ; exceeds revised guidance of$102 -$103 million -
Quarterly Non-GAAP diluted EPS of
$0.07 ; exceeds revised guidance of$0.03- $0.04 -
Quarterly Non-GAAP net income of
$4.1 million -
Quarterly Non-GAAP EBITDA of
$28 million -
Working capital increases
$21 million sequentially to$233 million -
Net cash increases
$22 million sequentially to$41 million
"Fourth quarter revenues reflect decreased demand for both integrated
circuit (IC) and flat panel display (FPD) photomasks during a
challenging global economic and electronics industry environment,"
stated Constantine ("Deno") Macricostas,
Sales for the fourth quarter of fiscal 2012 were
Sales for the 2012 fiscal year were
The section below entitled "Non-GAAP Financial Measures"
provides a definition and information about the use of non-GAAP
financial measures in this press release, and the attached financial
supplement reconciles non-GAAP financial information with
Non-GAAP Financial Measures
Non-GAAP net income attributable to
- Consolidation and restructuring charges in fiscal 2012 are excluded because they are not a part of ongoing operations.
- Impact of warrants is excluded because it does not affect cash earnings.
- Loss on extinguishment of debt in 2011 is excluded because it is not a part of ongoing operations.
The presentation of this financial information should not be considered
in isolation or as a substitute for the financial information prepared
and presented in accordance with accounting principles generally
accepted in
A conference call with investors and the media to discuss these results
is scheduled for
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements made by or on behalf of
15-2012
PLAB - E
|
||||||||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Information |
||||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||||
|
|
|
October 30, | |||||||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||||||||
Reconciliation of GAAP to Non-GAAP Net Income |
||||||||||||||||||||||
Attributable to |
||||||||||||||||||||||
GAAP net income attributable to |
$ | 3,833 | $ | 9,291 | $ | 27,868 | $ | 16,229 | ||||||||||||||
(a) Consolidation and restructuring charges, net of tax | 246 | - | 1,428 | - | ||||||||||||||||||
(b) Impact of warrants, net of tax | - | (175 | ) | (94 | ) | 424 | ||||||||||||||||
(c) Debt extinguishment loss and net interest impact, net of tax |
- | - | - | 35,486 | ||||||||||||||||||
Non-GAAP net income attributable to |
$ | 4,079 | $ | 9,116 | $ | 29,202 | $ | 52,139 | ||||||||||||||
Reconciliation of GAAP to Non-GAAP Net Income |
||||||||||||||||||||||
Applicable to Common Shareholders |
||||||||||||||||||||||
Weighted average number of diluted shares outstanding | ||||||||||||||||||||||
GAAP | 61,052 | 76,259 | 76,464 | 58,458 | ||||||||||||||||||
Non-GAAP | 61,052 | 76,082 | 76,445 | 71,940 | ||||||||||||||||||
Net income per diluted share | ||||||||||||||||||||||
GAAP | $ | 0.06 | $ | 0.14 | $ | 0.44 | $ | 0.28 | ||||||||||||||
Non-GAAP | $ | 0.07 | $ | 0.14 | $ | 0.46 | $ | 0.80 |
(a) Represents consolidation and restructuring charges
primarily related to restructuring in |
(b) Represents financing expenses related to warrants, which are recorded in other expense, net. |
(c) Represents extinguishment charges during the year ended
|
|
|
||||||||||||||||||||||||
Condensed Consolidated Statements of Income |
||||||||||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||||||
|
|
|
October 30, | |||||||||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||||||||||
Net sales | $ | 104,219 | $ | 122,159 | $ | 450,439 | $ | 512,020 | ||||||||||||||||
Costs and expenses: | ||||||||||||||||||||||||
Cost of sales | (79,922 | ) | (91,266 | ) | (338,519 | ) | (375,806 | ) | ||||||||||||||||
Selling, general and administrative | (11,396 | ) | (11,245 | ) | (46,706 | ) | (45,240 | ) | ||||||||||||||||
Research and development | (5,264 | ) | (4,269 | ) | (19,371 | ) | (15,507 | ) | ||||||||||||||||
Consolidation, restructuring and related charges | (246 | ) | - | (1,428 | ) | - | ||||||||||||||||||
Operating income | 7,391 | 15,379 | 44,415 | 75,467 | ||||||||||||||||||||
Debt extinguishment loss | - | - | - | (35,259 | ) | |||||||||||||||||||
Other expense, net | (1,623 | ) | (2,290 | ) | (3,767 | ) | (4,309 | ) | ||||||||||||||||
Income before income taxes | 5,768 | 13,089 | 40,648 | 35,899 | ||||||||||||||||||||
Income tax provision | (1,551 | ) | (4,054 | ) | (10,793 | ) | (15,691 | ) | ||||||||||||||||
Net income | 4,217 | 9,035 | 29,855 | 20,208 | ||||||||||||||||||||
Net (income) loss attributable to noncontrolling interests | (384 | ) | 256 | (1,987 | ) | (3,979 | ) | |||||||||||||||||
Net income attributable to |
$ | 3,833 | $ | 9,291 | $ | 27,868 | $ | 16,229 | ||||||||||||||||
Earnings per share: | ||||||||||||||||||||||||
Basic | $ | 0.06 | $ | 0.16 | $ | 0.46 | $ | 0.28 | ||||||||||||||||
Diluted | $ | 0.06 | $ | 0.14 | $ | 0.44 | $ | 0.28 | ||||||||||||||||
Weighted-average number of common shares outstanding: | ||||||||||||||||||||||||
Basic | 60,196 | 59,629 | 60,055 | 57,030 | ||||||||||||||||||||
Diluted | 61,052 | 76,259 | 76,464 | 58,458 |
|
||||||||||||||
Condensed Consolidated Balance Sheets |
||||||||||||||
(in thousands) | ||||||||||||||
|
October 30, | |||||||||||||
2012 | 2011 | |||||||||||||
Assets |
||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ | 218,043 | $ | 189,928 | ||||||||||
Accounts receivable | 75,685 | 85,540 | ||||||||||||
Inventories | 17,702 | 22,100 | ||||||||||||
Other current assets | 8,364 | 7,639 | ||||||||||||
Total current assets | 319,794 | 305,207 | ||||||||||||
Property, plant and equipment, net | 380,808 | 368,680 | ||||||||||||
Investment in joint venture | 93,252 | 79,984 | ||||||||||||
Intangible assets, net | 37,384 | 42,462 | ||||||||||||
Other assets | 19,356 | 21,521 | ||||||||||||
$ | 850,594 | $ | 817,854 | |||||||||||
Liabilities and Equity |
||||||||||||||
Current liabilities: | ||||||||||||||
Current portion of long-term borrowings | $ | 7,781 | $ | 5,583 | ||||||||||
Accounts payable and accrued liabilities | 79,092 | 90,318 | ||||||||||||
Total current liabilities | 86,873 | 95,901 | ||||||||||||
Long-term borrowings | 168,956 | 152,577 | ||||||||||||
Other liabilities | 8,764 | 9,620 | ||||||||||||
Equity | 586,001 | 559,756 | ||||||||||||
$ | 850,594 | $ | 817,854 |
|
||||||||||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||||||||||
(in thousands) | ||||||||||||||||
Year Ended | ||||||||||||||||
|
October 30, | |||||||||||||||
2012 | 2011 | |||||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income | $ | 29,855 | $ | 20,208 | ||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||||||
Depreciation and amortization | 85,209 | 93,460 | ||||||||||||||
Debt extinguishment loss | - | 27,399 | ||||||||||||||
Consolidation, restructuring and related charges | 262 | - | ||||||||||||||
Changes in assets and liabilities and other | 17,223 | (4,514 | ) | |||||||||||||
Net cash provided by operating activities | 132,549 | 136,553 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Purchases of property, plant and equipment | (96,978 | ) | (82,121 | ) | ||||||||||||
Investment in joint venture | (13,397 | ) | (18,271 | ) | ||||||||||||
Other | (1,568 | ) | (345 | ) | ||||||||||||
Net cash used in investing activities | (111,943 | ) | (100,737 | ) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||||
Proceeds from long-term borrowings | 25,000 | 17,000 | ||||||||||||||
Proceeds from issuance of convertible debt | - | 115,000 | ||||||||||||||
Repurchase of common stock of subsidiary | (15,598 | ) | (9,878 | ) | ||||||||||||
Repayments of long-term borrowings | (5,293 | ) | (64,107 | ) | ||||||||||||
Payments of deferred financing fees | (198 | ) | (4,318 | ) | ||||||||||||
Proceeds from exercise of share-based arrangements | 653 | 828 | ||||||||||||||
Net cash provided by financing activities | 4,564 | 54,525 | ||||||||||||||
Effect of exchange rate changes on cash | 2,945 | 642 | ||||||||||||||
Net increase in cash and cash equivalents | 28,115 | 90,983 | ||||||||||||||
Cash and cash equivalents, beginning of year | 189,928 | 98,945 | ||||||||||||||
Cash and cash equivalents, end of year | $ | 218,043 | $ | 189,928 |
Vice President,
Investor Relations & Marketing
pbroadbent@photronics.com
Source:
News Provided by Acquire Media